Uses
Permethrin Cream, 5% is indicated for the treatment of infestation with Sarcoptes scabiei (scabies).
Source: US FDA prescribing information
Molecule
Permethrin
Pyrethroid
Available on request
- Presentations
- 3
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Permethrin is a pyrethroid indicated for the treatment of infestation with Sarcoptes scabiei (scabies). It is available as cream for topical use. MedsAcross supplies Permethrin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Pyrethroid
- ATC classification
- P03AC04 Permethrin · Ectoparasiticide, subgroup P03AC
- US FDA first approval
- 31 March 1986
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Topical
- Dosage forms
- Cream
- Identifiers
- UNII 509F88P9SZRxCUI 33199CAS 52645-53-1DrugBank DB04930Q411635
Clinical information
From the regulator-approved product information. Each section names its source.
Dosing overview
Adults and Children - Thoroughly massage Permethrin Cream, 5% into the skin from the head to the soles of the feet. Scabies rarely infests the scalp of adults, although the hairline, neck, temple, and forehead may be infested in infants and geriatric patients. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing (shower or bath) after 8 to 14 hours. Infants should be treated on the scalp, temple, and forehead. ONE APPLICATION IS GENERALLY CURATIVE. Patients may experience persistent pruritus after treatment. This is rarely a sign of treatment failure and is not an indication for retreatment. Demonstrable living mites after 14 days indicate that retreatment is necessary.
Source: US FDA prescribing information
Contraindications
Permethrin Cream, 5% is contraindicated in patients with known hypersensitivity to any of its components, to any synthetic pyrethroid or pyrethrin.
Source: US FDA prescribing information
Warnings and precautions
If hypersensitivity to Permethrin Cream, 5% occurs, discontinue use.
Source: US FDA prescribing information
Side effects
In clinical trials, generally mild and transient burning and stinging followed application with Permethrin Cream, 5% in 10% of patients and was associated with the severity of infestation. Pruritus was reported in 7% of patients at various times post-application. Erythema, numbness, tingling, and rash were reported in 1 to 2% or less of patients. Other adverse events reported since marketing Permethrin Cream, 5% include: headache, fever, dizziness, abdominal pain, diarrhea and nausea and/or vomiting. Although extremely uncommon and not expected when used as directed, rare occurrences of seizure have been reported. None have been medically confirmed as associated with Permethrin Cream, 5% treatment.
Source: US FDA prescribing information
Storage
Store at 20° to 25°C (68° to 77°F) Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 032, India Revised: 03/2025
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
3 presentations of Permethrin, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Permethrin 5% creamTopicalGeneric name | — | US FDA | Available on request |
| Elimite 5% creamTopical | Aurobindo PharmaIndia | US FDA | Available on request |
| Permethrin 0.05% creamTopicalGeneric name | — | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Indian manufacturers are highlighted.
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 31 March 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions
Conditions linked to Permethrin in public data. This is not a list of approved uses, see the clinical information.
Questions and answers
Is Permethrin available for export from India?
Yes, on request. MedsAcross lists 3 presentations of Permethrin and sources them for licensed hospitals, importers and physicians against valid import documents. Indian manufacturers include Aurobindo Pharma.
What brand names does Permethrin have?
The catalogue lists 1 brand names for Permethrin, including Elimite.
Is Permethrin approved by the US FDA?
Yes. The US FDA first approved Permethrin on 31 March 1986, according to Drugs@FDA.
Does Permethrin need cold chain shipping?
No listed presentation of Permethrin is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Permethrin in?
Permethrin is classified under ATC code P03AC04 (Permethrin).
References
- PERMETHRIN prescribing information (Aurobindo Pharma). U.S. National Library of Medicine, DailyMed. Retrieved 4 March 2026
Request Permethrin for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.